| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue | 172 | 320 | 123 | | Cost of Revenue | 74 | 627 | 438 | | | Gross Profit | 98 | (307) | (316) | | | Operating Expenses | | Research Development | 15,114 | 6,028 | 3,894 | | Selling General and Administrative | 9,819 | 10,135 | 15,050 | | Non Recurring | 13,624 |
-
|
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (38,459) | (16,470) | (19,259) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (306) | 721 | 770 | | Earnings Before Interest And Taxes | (38,765) | (15,749) | (18,489) | | Interest Expense | 3,198 |
-
|
-
| | Income Before Tax | (41,963) | (15,749) | (18,489) | | Income Tax Expense |
-
|
-
|
-
| | Minority Interest | (3,522) |
-
|
-
| | | | Net Income From Continuing Ops | (45,485) | (15,749) | (18,489) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (45,485) | (15,749) | (18,489) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($45,485) | ($15,749) | ($18,489) |
|
0.31% Nasdaq 0.00%
Income Statement
